FDA Releases Two Discussion Papers to Spur Conversation about Artificial Intelligence and Machine Learning in Drug Development and Manufacturing AI technologies in manufacturing can enhance process controls, identify early warning signals, prevent product losses. AI/ML in Drug development has concerns like bias, errors, improper data sharing, algorithmic discrimination. FDA is issuing the discussion papers to spur discussions on addressing the concerns of AI/ML in Drug development and advance equity & address use of AI in manufacturing Read More..
Leave a Comment
You must be logged in to post a comment.